相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tau and neurodegenerative disease: the story so far
Khalid Iqbal et al.
NATURE REVIEWS NEUROLOGY (2016)
Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice
Julia Gerson et al.
JOURNAL OF NEUROTRAUMA (2016)
Glucose Metabolic Brain Networks in Early-Onset vs. Late-Onset Alzheimer's Disease
Jinyong Chung et al.
Frontiers in Aging Neuroscience (2016)
p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
Hai-long Dai et al.
SCIENTIFIC REPORTS (2016)
Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion
Catharina Lange et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Glucose deprivation increases tau phosphorylation via P38 mitogen-activated protein kinase
Elisabetta Lauretti et al.
AGING CELL (2015)
Pharmacologic Inhibition of 5-Lipoxygenase Improves Memory, Rescues Synaptic Dysfunction, and Ameliorates Tau Pathology in a Transgenic Model of Tauopathy
Phillip F. Giannopoulos et al.
BIOLOGICAL PSYCHIATRY (2015)
The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease
Naoyuki Sato et al.
Frontiers in Aging Neuroscience (2015)
Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease
Fernanda G. De Felice et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review
Stefan L. C. Geijselaers et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
TAU-MEDIATED SYNAPTIC DAMAGE IN ALZHEIMER'S DISEASE
Santosh Jadhav et al.
TRANSLATIONAL NEUROSCIENCE (2015)
Glucose deprivation induces reticulum stress by the PERK pathway and caspase-7-and calpain-mediated caspase-12 activation
Selene Garcia de la Cadena et al.
APOPTOSIS (2014)
Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice
Antonio Di Meco et al.
NEUROBIOLOGY OF AGING (2014)
Glycemic Variability and Acute Ischemic Stroke: The Missing Link?
Emmanuel I. Gonzalez-Moreno et al.
TRANSLATIONAL STROKE RESEARCH (2014)
Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
Geert Jan Biessels et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells
Ana Catarina R. G. Fonseca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
5-Lipoxygenase Activating Protein Reduction Ameliorates Cognitive Deficit, Synaptic Dysfunction, and Neuropathology in a Mouse Model of Alzheimer's Disease
Phillip F. Giannopoulos et al.
BIOLOGICAL PSYCHIATRY (2013)
Sugar for the brain: the role of glucose in physiological and pathological brain function
Philipp Mergenthaler et al.
TRENDS IN NEUROSCIENCES (2013)
Soluble forms of tau are toxic in Alzheimer's disease
Katherine J. Kopeikina et al.
TRANSLATIONAL NEUROSCIENCE (2012)
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
Cristian A. Lasagna-Reeves et al.
MOLECULAR NEURODEGENERATION (2011)
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Lenka Munoz et al.
NEUROPHARMACOLOGY (2010)
Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Manuela Polydoro et al.
JOURNAL OF NEUROSCIENCE (2009)
AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation
Win D. Cheung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis
Tracy O'Connor et al.
NEURON (2008)
Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells
Metin Kurtoglu et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Energy inhibition elevates β-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice:: Possible early events in Alzheimer's disease pathogenesis
RA Velliquette et al.
JOURNAL OF NEUROSCIENCE (2005)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5
QW Wang et al.
JOURNAL OF NEUROSCIENCE (2004)
Tau phosphorylation in Alzheimer's disease - Potential involvement of an APP-MAP kinase complex
AL Peel et al.
NEUROMOLECULAR MEDICINE (2004)
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the nun study
KP Riley et al.
ANNALS OF NEUROLOGY (2002)
Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry:: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β
CH Reynolds et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
